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Abstract

Introduction

Using ethylene glycol (EG) and vitamin D3 as crystal-inducing diet (CID) in rats, we investigated the effect
of the dosage of EG on the generation of chronic calcium oxalate (CaOx) nephrolithiasis. We collected weekly
24 hour urines and measured herein the amount of oxalate, calcium, glycosaminoglycans (GAG's), creatinine,
protein, alkaline phosphatase (AP), "(-glutamyl transpeptidase ("(-GT), and N-acetyl-13-glucosaminidase (NAG).
The potential of these urines to inhibit crystal growth
and agglomeration was also evaluated. After four
weeks, the kidneys were screened by histology and
radiography for the presence of CaOx crystals and the
amount of kidney-associated oxalate was biochemically
measured. Using 0.5 vol.% EG, only a part of the rats
showed CaOx deposition in the renal cortex and/or medulla, without obvious differences between Wistar and
Sprague-Dawley (SD) rats. If a dietary EG concentration of 0. 75, 1.0. or 1.5 vol.% was used, the amount of
kidney-associated oxalate was proportionally higher and
CaOx crystal formation was consistently found in all
rats. Most crystals were encountered in the cortex,
whereas in the medulla and the papillary region , crystals
were only occasionally detected. From these data, we
conclude that in the chronic rat model, based on EG and
vitamin D3 , a consistent deposition of CaOx crystals is
obtained using a EG concentration of at least 0. 75 %.

Hyperoxaluria is a major risk factor in calcium oxalate (CaOx) stone disease. Apart from the so-called
"idiopathic" stone forming patients, in which stone formation is attributed to diurnal and seasonal variations in
oxalate absorption [17), hyperoxalurias mainly occur in
patients with inborn errors of metabolism [14). Such
patients have recurrent CaOx stones that lead to progressive renal failure and death at an early age.
Several animal models have been proposed to extend
the understanding of the etiology of human stone dis~se
[3, 23, 34, 41). In rats, hyperoxaluria can easily be induced by various diets. Most of these diets are based on
increasing the oxalate production by administration of
oxalate precursors such as ethylene glycol (EG) [3, 23).
Moreover, in the rat kidney, the physiology and distribution of oxalate among cortex, medulla, and papilla, is
reported to be similar to that in the human kidney [19) .
For studies on experimental nephrolithiasis, two
types of rat models are currently available [23) : acute
and chronic models. In the acute models, animals are
challenged with a relatively large dose of lithogen and
the urinary oxalate load is increased within minutes (21,
25). Brigman and Finlayson [1] used a single intraperitoneal injection of sodium oxalate to test the efficiency
of various drugs in reducing the precipitation of intratubular CaOx salts within the renal tubules. Although in
the acute models, induced hyperoxaluria is followed by
crystalluria and formation of CaOx crystals within the
renal tubules and the interstitium, renal stones are not
formed . In the chronic models, rats are continuously
challenged with smaller doses of lithogen for a longer
period, up to 30 days (2, 9, 10, 11, 19). In this model,
the CaOx crystals formed are retained long enough within the tubular system to be deposited in the interstitium.
Several chronic models are available. Buck et al.
(2) used daily injections of calcium gluconate to introduce nephrocalcinosis. In the present study, we focused
our attention on the chronic vitamin D3 /EG model. This
model, originally described by Okada et al. (32] and
modified later by Reis-Santos et al. (35), is based on the
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Table 1. Wistar and SD rats used for the CID experiment of vitamin D 3 + 0.5% EG . At the indicated
points of time the urines were collected and the animals
sacrificed. (SD
Sprague Dawley rat).

formation of intratubular CaOx crystals as a result of the
supersaturation, generated by the vitamin Drinduced enhancement of urinary calcium concentrations and EG-induced hyperoxaluria [33). In order to further characterize the model, and to define the conditions consistently
leading to CaOx deposition in the rat kidneys , we investigated the following parameters: (1) The urinary excretion and renal deposition of CaOx at successive points
of time of feeding the vitamin D3 and 0.5 % EG . (2)
At that point of time at which, with 0.5 % EG , most
renal crystals were encountered, the effect of increasing
EG-concentrations on the renal deposition of Ca Ox crystals. In addition, the urinary excretion of glycosaminoglycans (GAG's) and the urinary inhibitory activities of crystal growth and agglomeration were investigated. Possible kidney damage was assessed by following the urinary excretion of creatinine and the release of
protein and renal enzymes into the urine.

Rat number
Wistar/SD

+2
3 + 4
5 + 6
7 + 8
9 + 10
11 + 12
1

Diet

Day of
urine collection

Day of
sacrifice

standard

0 ,7, 14,2 1,28,42

42

CID

0 , and 7

7

CID

14

14

CID

21

21

CID

28

28

CID

42

42

individually kept in metabolic c.:ages and the urines were
collected on ice without any preservative during 24
hours. The volume and the pH of each urine were
measured . This pH was between 6 .0 and 8.5. To one
ml urine samples, 6 µI concentrated HCI was added and
they were then analyzed for oxalate, calcium, magnesium, and phosphate. The remaining unacidified urine
was centrifuged at 1000 x g for 10 minutes and the obtained supernatant was analyzed for creatinine, protein ,
alkaline phosphatase (AP), -y-glutamyl transpeptidase
(-yGT) and N-acetyl-B-glucosa minidase (NAG). For all
analyses, including the ions, Merck kits (Merck Diagnostica, Darmstadt, Germany), adapted to an EppendorfMerck ELAN autoanalyser, were used. These assays
were performed as prescribed by the manufacturer. The
oxalate assays were performed with an enzymatic kit
from Sigma, which is based on the oxidation of oxalate
to CO 2 . The resulting H 2 0 2 was measured by the formation of a blue indam.ine dye, with a maximum absorption at 590 nm . For each oxalate assay, 0.5 ml urine
was mixed with an equal vo lume sample buffer (final pH
5.0-7.0). Of thi s mixture, 0.5 ml was pipetted in an
Eppendorf tube, thoroughly mixed with 50 mg active
carbon , and centrifuged at 10,000 rpm in a microcentrifuge for 2 minutes. Of the supernatant, 90 µI was used
for the oxalate assay with autoanalyser. Using the oxalate standards of the test kit, the detection limit was 0.08
µmo! oxalate/ml urine. Urinary GAG's were measured
using 1,9-dimethylene blue as substrate [12). Urinary
inhibitory activity was assessed by measuring the potential of the collected urines to inhibit growth and aggregation of CaOx seed crystals in a metastable solution [39).
The pellets of the centrifuged unacidified urines (see
above) were analyzed for the presence of CaOx crystals
by Fourier-transform infrared spectroscopy (FTIR) [8] .
For this purpose , the pell ets were washed by resuspension in water, followed by centrifugation at 3000 rpm,

Materials and Methods
Thirty-three male Wistar and Sprague Dawley (SD)
rats weighing 250-300 g were obtained from the Central
Animal Breeding Centre (Harlan, Zeist, The Netherlands). After arrival , the rats were acclimatized for
seven days . All rats had free access to 40 ml drinking
water every day. Mild chronic hyperoxaluria was induced by EG and vitamin D 3 (Sigma, St. Louis, MO,
USA). EG was suppl emented to drinking water to a final concentration of 0.5 vol.% or higher. Vitamin D3
was di ssolved in cottonseed oil (Sig ma) at a concentration of one µg lml , of which, compulsorily , 0.5 ml was
orally administrated by stomach intubation every other
day. Control rats did not receive vitamin D 3 and EG
had been omitted from their drinking water. All rats
received a standard rat chow (Diet AM II, Hope Farms,
Woerden , the Netherlands), consisting of (in weight %,
wt. %) : rough protein (23. 3 %) , fat ( 6 .4 %) , rough cell
compound (3 .2%), rough ash (4.4%), and a salt mixture, containing phosphorus (0.48 %), magnesium
(0. 12 %), sodium (0 .24%), and potassium (0.8%). The
calcium content varied per batch between 0.56-0.83 %
(mean: 0.70%) .
Urines were collected at the following points in
time, for each animal separately. For the first experiment, in which vitamin D 3 + 0.5 % EG was used as
crystal-inducing diet (CID), these urines were collected
at days 0, 7 , 14, 21, 28 and 42. The animals were sacrificed at the indicated points in time (Table 1). For the
second experiment, in which vitamin D 3 and three increasing EG concentrations were used as CID, viz.,
0.75% (group I), 1.0 % (group II) and 1.5 % (group III),
the urines were collected at days 0, 6, 9 , 14, 20 and 28.
Each group consisted of three animals. The rats were
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Table 2. Calcium and oxalate excretion of Wistar and SD rats fed the standard chow and rats fed a CID of vitamin
D 3 and 0.5 % EG for the indicated points of time. At day O also all CID-fed rats were fed the standard chow. All Data
are expressed as µmol/24 h. The data of the Wistar rats are also shown in Figure 1 (lA: calcium; and lB: oxalate).
Rat
Type

Rat
Number

Diet

0

7

14

Experimental day
28
21

42

Mean± s.d.*

Calcium excretion
Wistar
Wistar
Wistar
Wistar

1
2
3-7
6-12

standard
standard
CID
CID

17.o·
7.7 ..
8.9 ..
11.9•

7.3 ..
15.8 ..
0.6
9.3

17.8 ..
23_0·
6.4
11.3

15.9 ..
12_5•
10.6
4.6

29.2 ..
33_0·
8.9
4.3

26.3 .. )
20_5•)
25.3
11.4

17.6 ± 8.o·

SD
SD
SD
SD

1
2
3-7
6-12

standard
standard
CID
CID

11.7V
8.3v
18.3v
20.7v

20.2V
28.2V
4.8
8.0

19.8v
26.0v
9.7
9.5

11.lV
8.7v
2.2
8.9

32.3v
39. lV
14.4
10.0

10.4V)
15.4V)
1.2
5.8

19.3 ± 9.4V

13.2..
7.4•
98.0
62.4

8.2·
10.2·
54.3
12.0

4.8 ..
10.5 ..
57 .6
33.6

9. 1• )
8.6 .. )
36.6
29.8

8.8 ± 2.0·

9.9V
8.9v
18.3
45.6

15.6v
16.2v
85. 1
86.6

8.9v
9.0v
81. 7
34.1

7.8v)
14.4V)
12.2
17.3

9.1 ± 3.9V

Oxalate excretion
Wistar
Wistar
Wistar
Wistar

1
2
3-7
8-12

standard
standard
CID
CID

9.9 ..
6.4 ..
8.1 ..
7.8 ..

SD
SD
SD
SD

1
2
3-7
8-12

standard
standard
CID
CID

3.7V
4.3V
6.5v
5.2v

10.5 ..
9. 1..
8.9
37.6
9_3V
8. lV
41.1
15.5

*Pooled data of all Wistar rats (*) and SD rats (v) fed the standard chow (for 0, 7, 14, 21, 28, and 42 days) .
digestion buffer. The digestions were performed for 24
hours in a water bath at 45-50°C. The suspensions were
centrifuged for 10 minutes at 1000 x g. The pellet with
the crystals was dissolved in 0.3 N HNO 3 and the
amount of oxalate was measured in the pellet and supernatant as described above. All data were expressed as
µmo! oxalate per kidney and statistically analyzed by
Kruskal-Wallis 1-way ANOV A tests .
The urinary data are presented as mean ± standard
deviation (s.d.). Since the number of data was too low
to assume a normal distribution, non-parametrical tests
were used for the statistical analyses: (1) for the detection, for each point in time, possible differences between
the CID-fed rats and the rats fed the standard diet (day
0) Wilcoxon matched-pairs tests were used. The reason
for this approach was that both populations were formed
by the same rats. In these analyses, the data of group
I-III were pooled for each point in time and compared
with the data of the rats fed the standard diet (day 0).
Significant differences (p < 0.05) are indicated in the
various figures (*) . (2) For the detection, for each
point in time, of differences between the three groups

dried and pulverized. The crushed crystals were mixed
with 200 mg KBr and analyzed with a Biorad FTS-7
(Veenendaal, The Netherlands).
At 28 days, the rats were anaesthetized with diethylether, followed by an intramuscular injection with a 12
wt.% solution of urethane (Fluka, Buchs, Switzerland)
in physiological saline at a dose of 1 ml per 100 g body
weight. The kidneys were perfused through the abdomi nal aorta with physiological saline. Small pieces of the
cortex and medulla of the right kidneys were excised,
fixed with 4 % paraformaldehyde and embedded in paraffin. The tissue sections were stained with haematoxylin/eosin (HE) and examined by light microscopy.
The right and left kidneys were weighed and
scanned by radiography for the presence of CaOx crystals. The right kidneys were homogenized as follows :
the cortical/medullary- and the papillary part were digested in 6 ml, respectively, 1 ml digestion buffer,
consisting of 10 mmol Tris-HCl (pH 8.0), sodium dodecyl sulphate (SDS; 1 wt.%) and proteinase K (0.14
mg/ml) (Glenny RW, personal cornnrnnication, 1993).
The left kidneys were entirely homogenized in 7 ml
593
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Calcium excretion

Kidney-associated oxalate
µmol

µmol/24 h

10 ~ - - -- --

30

- - - - -- - --

~

A
25
20
15

10
5
0

"

0

7

I

14

21

I

0

28

42

7

14

21

28

42

CID (days)

CID (days)

Oxalate excretion

Figure 2. Oxalate content in kidneys of control and
CID-fed animals. The cortical/medullary regions are indicated with the hatched areas and the papillary regions
with the solid areas. The results are presented as data
of individual rats.

µmol/24 h
140 ~ - - - - - - - - - - - - - - - - -

8
120
100

Since it has been reported that after phosphorus- and
vitamin B6 deprivation, SD rats have a higher urinary
oxalate excretion than Wistar rats [45], we performed,
using the CID of vitamin D3 and 0.5 % EG, a duplicate
experiment with SD rats.

80
60

Urinary excretion of calcium and oxalate: In control rats, the urinary calcium excretion varied between
10-30 µmol per 24 hours. During the first three weeks
of CID, all rats showed a reduced urinary calcium excretion, although this decrease was less pronounced at
28 and 42 days (Fig. IA, Table 2). The oxalate excretion increased considerably after CID, but also varied
between the individual animals (Fig. lB, Table 2).
Maximal values were obtained at 14, 21, and 28 days.
The urinary calcium/oxalate ratio was 2.2 ± 1.5 in
control rats, whereas in CID-fed rats, this ratio was
always lower than 0.4.

CID (days)

Figure 1. Urinary excretion of calcium and oxalate in
control (open bars; mean ± s.d. ; n = 4) and CID-fed
animals at the indicated points of time (hatched bars;
presented as data of individual rats). (A) Calcium
excretion; (B) Oxalate excretion.

Kruskal-Wallis 1-way ANOV A tests were used. The existence of significant heterogeneity (p < 0.05) between
these group is indicated in the various figures ( 0 • ) . (3)
To detect, for each urinary parameter, significant (p <
0.05) time-related changes, Friedman two-way ANOV A
tests were used .

Kidney-associated oxalate: The kidneys of control
rats contained approximately 0.4 µmol oxalate. During
the first three weeks of CID the amount of oxalate was
slightly increased. Considerably higher values were observed at 28 and 42 days, with a wide variation between
the individual animals (range: 0. 8-7 .9 µmol, respectively, 1.0-9.0 µmo!) . Of the total kidney-associated
oxalate ranging 0.06-1.6 µmol, maximally 0.04-0.9
µmo! oxalate, respectively, was associated with the papilla at these points of time (Fig. 2).

Results
Time course study

In initial experiments with Wistar rats, we administered a CID of vitamin D 3 and 0.5 % EG and examined
the urinary excretion and renal deposition of calcium and
oxalate. In addition, the composition of the excreted
urinary crystals was determined. The results are presented below as data of individual rats and compared
with rats fed only the standard chow (control rats).

Analyses of urinary crystals: The urinary crystals
of the control rats consisted predominantly of phosphate
with calcium or magnesium (apatite and struvite). CaOx
monohydrate crystals (whewellite) were encountered, but
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Kidney-associated oxalate

Calcium excretion
µmol

µmol/24 h
30 ~ - - - - - - - - - - - - - - - - - ~

A

*

25

*
400 .

20

*

15

CID (days)

Total kidney

Papilla

Figure 4. The effect of the concentration of dietary EG
on the oxalate content of (1) the total kidney, (2) the
cortex/medulla, and (3) the papilla. The animals were
fed the CID of EG and vitamin D3 for 28 days. Each
bar represents the mean of three animals(± s.d.). Mutual differences between the three groups in oxalate deposition are indicated('"'"'"; p < 0.06). The EG concentration in the drinking water is displayed similar to that
in Figure 3.

Oxalate excretion
pmol/24 h
200 ~ - - - - - - - - - - - - - - - - - -

B

*

Cortex + medulla

*

crystals. In this study, we investigated whether increasing the EG concentration in the drinking water to
0.75% (group I), 1.0% (group II), and 1.5% (group
III), respectively, achieved a consistent deposition of
renal crystals. The results of this study, in which we
also followed the various urinary parameters, are presented below.

CID (days)
~ 0.75% EG + vii. D ~ 1.0 % EG + vit D ■ 1.5% EG + vit D

Urinary excretion of calcium and oxalate: Compared to the control animals, the excretion of calcium
was reduced at all points of time after CID (p < 0.05),
without differences between the three groups (Fig. 3A) .
The oxalate excretion had increased considerably after
CID (p < 0.008), without differences between the
groups, and without observable changes with time (Fig.
3B). The calcium/oxalate ratio was 2.6 ± 1.6 in
control animals (n = 6), whereas in group II and III this
ratio was always lower than 0.4. No changes were
observed in magnesium and phosphate excretion.

Figure 3. The effect of the concentration of dietary EG
on the urinary excretion of calcium and oxalate. Each
bar represents the mean (± s.d.) of nine animals (open
bars; controls) or three animals (hatched bars; CID-fed
animals). Significant differences with the control rats
are indicated(*). The EG concentration in the drinking
water is displayed in the box at the bottom of Figure 3.
(A) Calcium excretion; (B) Oxalate excretion.
only in low percentages(~ 5%). During the first three
weeks of the CID, whewellite crystals were slightly
more often found (2-10%), but most frequently at both
28 and 42 days (2-50 %). CaOx dihydrate crystals (weddellite) were only observed at day 42 (0-20 %).

Kidney-associated oxalate: In group I, the amount
of oxalate in the total kidney was 17.8 ± 12.2 µmo!, of
which 1.0 ± 0.6 µmol was associated with the papilla.
In the cortex and medulla, the amount of oxalate was
higher in group II and III, but not yet significant (p =
0.06). The quantity of oxalate in the papilla remained
at the same low level (Fig. 4) . Histological examinations and evaluation of the radiographs showed that all
kidneys had small crystals. These crystals were present

Effect of the EG concentration in the CID
In a previous study [13], we found that a CID of
vitamin D3 and 0.5 % EG lead in only eight (53 %) of the
fifteen CID-fed animals to renal deposition of CaOx
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40.0 ± 5.5%, respectively. Both activities were reduced after CID (p < 0.03, p < 0.02, respectively).
Only at day 9, the IA was dependent of the EG concentration (Figs. 6A and 6B; p = 0.05 with the KruskalWallis test). A time-dependency was observed for the
IG, probably caused by the relatively high values at 14,
20, and 28 days (p < 0.03).

it is about 0.25 µmol/ml. In idiopathic stone formers,
the urinary oxalate concentration lies between 0 .25-0.40
µmol/ml, and in hyperoxaluric patients, between 0.4-0. 8
µmol/ml [7]. In vitro studies have shown that in human
urine, crystal formation rises if urinary oxalate concentration exceeds about 0.4 µmol/ml [17].
The rat differs from man in the low incidence of
renal stones instead of crystals and the occurrence of
crystals within the cortex rather than the medulla [15 ,
29]. In addition, vitamin D 3-induced nephrocalcinosis
involves the early parts of the proximal tubule located in
the superficial cortex [3]. These data agree with the results of the present study. Examination of the radiographs showed that crystal deposition in the renal papilla
only increased at EG concentrations of 1.0 % and higher.
Our biochemical analyses showed that the increase of
oxalate associated with the papilla was low, compared to
the large increase in the total kidney.
Calcium oxalate crystals have also been experimentally induced in the kidneys of non-human primates, but
the required EG dose (15 mg/kg) is much lower than
that for rats [36]. In our experiments, the optimum concentration of EG in drinking water was about 0. 75-1 % ,
which corresponds to a daily dose of 750-1000 mg/kg.
This is, however, far below the LD 50 (the amount of a
substance that would be required to kill, within a specified time period, 50 % of the individuals in a large population of animals or organisms) for rats of 4700 mg/kg
after oral adm.inistration [40]. Chronic administration of
EG at concentrations higher than l % may, however,
cause toxic symptoms, such as nephrotoxicity and/or
generalized metabolic acidosis and early death [20].
Although calcium and oxalate may both promote
crystalluria and renal crystal formation, there are a number of indications that in humans, at calcium/oxalate
ratio's larger than one, an increase in urinary oxalate
concentration has a greater effect on the formation of
CaOx crystals than comparable changes in urinary calcium [37, 38, 43]. It is indisputable that between healthy
individuals and idiopathic stone formers, there are relatively small differences in urinary oxalate concentrations
(usually less than 0.1 µmol/ml). Other evidence for an
important role for oxalate comes from clinical studies.
Also, particle size measurements in urines of recurrent
stone formers showed that the volume of CaOx crystals
is related to the urinary oxalate and not to the urinary
calcium concentration [38].
In the present study, we that the excretion of calcium was lower in CID-fed than in control rats. In the
control rats, the calcium/oxalate ratio was 2.6 ± 1.6,
whereas, after CID of vitamin D3 and EG, this ratio was
always lower than 0.4. This indicates that in hyperoxaluric rats, the urinary calcium concentration is the ratelimiting step for the formation of CaOx crystals. The

Excretion of creatinine, protein and enzymes:
Compared with control rats, the excretion of creatinine
and NAG was roughly 20-30% reduced after CID (Figs.
7 A and 7C). This decrease was not significant. Significantly lower values were found for the release of protein
at day 9, 14, and 20 (p < 0.04; Fig. 7B) and AP at day
9, 14, and 24 (p < 0.05; Fig. 7D). Compared with the
control rats, the activity of -y-GT was significantly
reduced at day 6, 14, 20, and 28 (p < 0.05). The excreted amount of -y-GT was related with time (p <
0.04) and, at day 9, 20, and 28, also related to the
amount of EG in the CID (p < 0.05; Fig. 7E).

Analyses of urinary crystals: The urinary crystals
of the control rats consisted predominantly of phosphate
with calcium or magnesium (apatite and struvite). CaOx
monohydrate crystals (whewellite) were encountered, but
only in low percentages (:::;; 5 %). During the first three
weeks of the CID, whewellite crystals were found slightly more often (2-10 %), but most frequently at both 28
and 42 days (2-50%). CaOx dihydrate crystals (weddellite) were only observed at day 42 (0-20%).
Discussion
For generation of CaOx crystals in the rat kidney,
several diets have been described. It has been reported
that after phosphorus and vitamin B6 deprivation, SD
rats show a stronger CaOx response than Wistar rats
[45]. Using EG and vitamin D 3 as CID, we could not
confirm this finding. Khan et al. [22] found that adm.inistration of 0. 75 % EG through drinking water for 24
days did not result in a consistent renal deposition of
crystals. The fact that we found, in our experiments
with this EG concentration, a consistent renal crystal retention, might be related to the additional administration
of vitamin D 3 .
The present results of the oxalate assays on the kidney homogenates and the collected urines confirm earlier
observations [23] that for crystal formation in rat kidney , a severe hyperoxaluria is required. A prominent
renal crystal retention occurred only in those animals
with a daily oxalate excretion of 80-100 µmol. Assuming a production of 30 ml urine per day , this value corresponds with a urinary oxalate concentration higher
than 3 µmol/ml. In stone-forming patients, the urinary
oxalate concentration is much lower . In healthy adults,
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Figure 7. The effect of the concentration of dietary EG
on the urinary excretion of creatinine (A) , protein (B),
and the renal enzymes NAG (C), AP (D), and -y-GT
(E) . Significant differences with the control (*) group
and within the three CID groups (•••) are indicated.
The excretion of NAG and -y-GT changes with time (p
< 0.05). The EG concentration in the drinking water
is displayed conform the legend of Figure 3.
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fact that the calcium excretion in these rats was lower
than in the control rats remains unexplained. This may
be related to a reduced daily food consumption, since
during CID diet, we observed a significant decrease in
body weight in all animals, especially when the higher
EG concentrations of 1.0 and 1.5% were used.
Crystal formation is considered to be the result of
an imbalance between supersaturation and the presence
of crystallization promoters on the one hand and inhibitor activity on the other [44] . In urine, a number of
macromolecular inhibitors are present, among which
GAG's, nephrocalcin and Tamm-Horsfall protein have
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been investigated most extensively [4, 5, 6, 44]. Osteopontin is, quantitatively, another macromolecular inhibitor in urine. It is present in the epithelial cells of the
thin descending loop of Henle and in the papillary surface epithelium [28]. The synthesis of this glycoprotein
is increased by vitamin D3 and the control element has
been found in the promoter region of the osteopontin
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gene [30]. If, after a CID of vitamin D 3 and EG, the
synthesis of osteopontin is increased, a rise in inhibitor
activity would be expected. If osteopontin is an inhibitor of crystal agglomeration, then, this is evident on
day 9 (Fig. 6B). However, the question of which inhibitors contribute to the observed reduced urinary inhibitory activity after CID deserves further attention, e.g., by
measuring the urinary concentration of individual
GAG's, osteopontin, Tamm-Horsfall protein, nephrocalcin and citrate.
In the present study, the CID induced evidently not
only severe hyperoxaluria, but it also reduced the potential of the urines to inhibit crystal growth and agglomeration. In addition, there can be a lower production of
urinary inhibitors; the observed reduction may have been
due to co-precipitation of the inhibitor with CaOx crystals. During growth and agglomeration, these crystals
can bind macromolecular inhibitors and the absorbed
layer has been visualized by light- and electron-microscopy [13, 26]. Another explanation for the observed reduction in urinary inhibitory activity may be that, in our
hyperoxaluric rat urines, less ionic calcium is available.
Most inhibitors require free calcium for crystal binding
[18).
It is known that hyperoxaluria with renal CaOx deposition is harmful to the tubular epithelium. Several
studies have shown that oxalate ions and CaOx crystals
enhance the release of the renal enzymes AP, 1-GT, and
NAG [16, 24, 27). In the present study, however, the
release of protein and renal enzymes was reduced within
seven days after a CID of 0. 75 % EG and vitamin D 3 .
For r-GT, this reduction was even more pronounced, if
the higher EG concentrations of 1.0 and 1.5% were
used. Stonard et al. [42) also failed to find an increase
in either NAG, AP, or protein in rats with nephrocalcinosis. Nouwen et al. [31), after injury of the renal
epithelial cells, found a temporary loss in the expression
of epidermal growth factor, Tamm-Horsfall protein ,
transferrin receptor and in lectin binding. From these
considerations, it can be concluded that a CID of vitamin D3 and EG in all likelihood induces renal damage.
This damage may result in a decreased protein-synthesis
and a lower release of proteins and renal enzymes at
later points of time. In addition, it is conceivable that
the urinary enzymes and other urinary glycoproteins absorb to the CaOx crystals during aggregation and agglomeration, and coprecipitate during renal deposition.
Both processes can occur at the same time.
From the above considerations, we conclude that a
CID of vitamin D3 and 0.5 % EG gives rise to crystalluria and a highly variable crystal deposition in the renal
cortex. A higher EG concentration of 1.0, respectively,
1.5 %, results in a proportionally higher crystal deposition in the cortex, whereas in the papilla, it remains at

the same level and induces renal damage. We conclude
that for a consistent deposition of CaOx crystal, an EG
concentration of 0. 75 % is required.
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vantage and weakness of the Counter model used in our
laboratory have been recently discussed [47].

R.L. Hackett: What is the definition of nephro-calcinosis? Please explain the difference between it and crystallization and crystal localization.
Authors: Nephrocalcinosis is defined as crystal deposition outside the calyx and the tubular system, i.e., in the
cortical and/or in the medullary parenchyma.
R.L. Hackett: In Materials and Methods, the text implies as though you checked crystalluria on urines that
had been continuously iced throughout the collection period. If so, what do the authors conclude about the
crystals that were salted out in this process?
Authors: The wish to preserve the activities of urinary
enzymes and to prevent bacterial growth left us no other
choice than to collect the urines on ice. Although we
cannot exclude the possibility that the low temperature
salted out CaOx monohydrate and dihydrate crystals, it
must be realized that, in all likelihood, the urinary
inhibitors of crystal growth and agglomeration are still
effective at this low temperature.
R.L. Hackett: I am curious to know whether or not
you provided the animals with a "mush" form of rat
chow. Providing mush is important in regulating the animals dietary intake as well as limiting the contamination
of the urine collectors. Also, it does not appear that the
animals were "pair fed". Was the intake of EG monitored? In our experiments, some animals, if left to
drink ad libitum, will take excessive quantities of this
fluid . It al so appears that there were no control animals
that were intubated, stressful and invasive procedure.
Would the authors enter into more detail of these points?
J.P. Kavanagh: Ideally each experimental group of rats
would have a relevant control group , randomly selected
from aged and weighed animals. They should be studied
at the same time and housed under the same conditions.
It is not clear if this was always the case. Did the
different groups differ in their consumption of EG-containing water? Did the control rats receive placebo
intubations?
Authors: All rats were of the same age and weight.
They were housed under the same conditions and for the
same period of time. The rats were fed standard chow
in form of pellets. The rats were individually housed,
the EG intake was not followed. We observed that all
rats, fed either the standard chow or the CID of vitamin
D 3 and O. 5 % EG, consumed on the average 40 ml water
each day. In pilot experiments, we found that the rats
drank excessive amounts of EG containing water, if we
increased the EG concentration in the drinking water to
0.75%, 1.0, or 1.5%. Hence, in this series of dietary

Discussion with Reviewers
R.L. Hackett: In Figures 6A and 6B, you illustrate
crystal growth and agglomeration inhibition. Although
apparently not statistically different , there appears to be
a trend that growth is inhibited less than agglomeration,
especially in the 1.5 % EG and vitamin D3 group at earlier time periods. Could you provide an explanation for
this phenomenon?
Authors: According to Ryall ' s group [39, 46), the
Coulter Counter model has been used to characterize
calcium oxalate monohydrate (COM) seeded crystal
growth and agglomeration in the absence and presence
of the rat urine. It is well known that crystal growth
and agglomeration are different physico-chemical processes with different mechanisms, but they occur simultaneously in the test system used. The crystal growth
and agglomeration can be independently evaluated based
on changes in the total particle numbers and volumes
measured by the Coulter Counter. This trend reflects
two possibilities: (1) The components (inhibitors/promoters) in rat urines that may influence COM crystallization have been changed as a consequence of the CID.
(2) The mechanisms that controls crystal growth and agglomeration might be different. Because of the increased number of particles, the possibility that the presents results are due to a second nucleation induced by
the addition of the urines cannot be excluded. The ad601
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first 3 weeks, all rats showed reduced calcium excretion
does not fit with the finding in this figure that two
samples during this time period showed calcium excretion within the range quoted for the controls. What was
the oxalate range of the control animals? Were there
any real changes in excretory patterns over time
observed for the controls?
Authors: As shown in Table 2, the Wistar and SD rats,
fed the standard chow, showed no prominent differences
in calcium excretion. These data have a mean of 18.5
± 8.6 µmol/24 h (range: 7 .3-39.1 µmol/24 h). If in
this experiment, for each point of time all data of the
CID-fed Wistar and SD rats are pooled a lower calcium
excretion is calculated at day 6 and 14, although not yet
significant in the Wilcoxon matched-pairs test (p <
0.07).

experiments, the daily ration of drinking water was
limited to 40 ml. The control rats did not receive
placebo intubations. As far as we could verify, the animals tolerated the intubations were very well. It appeared essential, however, that the intubations were
performed by a trained biotechnician.

R.L. Hackett: In our laboratory, we have found that
kidney/papilla oxalate content needs to be normalized by
either protein or by weight. For one reason, since the
papilla tissue is so small, alterations of its values are
often masked. We find that the kidneys of these animals
often become enlarged as well and that lyophilization before digestion is useful in determining true alterations in
oxalate content. We have found that expressing [Ox]/
kidney is not necessarily useful information. Would you
like to comment on this point?
Authors: Indeed, biochemical determinations are normally related to the amount of protein. There are two
reasons why we abandoned this approach. First, the oxalate determinations were performed on kidney digests,
produced by proteinase K treatment. Protein determinations on such digests may not be reliable. Secondly, in
the kidney crystal deposition gives rise to an enlargement of the interstitium, predominantly caused by an increase of the number of interstitial cells and by an increase of the interstitial matrix. Thus, it is likely that
the amount of kidney protein is higher, if the number of
interstitial crystals is increased. Both drawbacks are
avoided if the oxalate determinations are related per
whole kidney . We also agree that the excision of papillary tissue is inaccurate. However, one must realize
that, in the papilla, most of the oxalate is present in
small stones. This means that in the papilla, the amount
of oxalate varies more according to the absence or presence of small stones than to the changes in the amount
of protein. Thus , the distribution of oxalate over the
papilla and the remainder of the kidney seems to be less
dependent on the protein ratios of both compartments.

E.J. Nouwen: Does the observation that the caicium
excretion is reduced after CID indicate that vitamin Dr
stimulated calcium uptake in the experimental rats might
be lower than the normal calcium uptake in the control
rats? Also, although the authors mention that the decrease in body weight (which might better be accurately
specified) was especially evident in the animals treated
with the highest EG dose of 1 and 1.5 %, this appears
not to be correlated with the urinary calcium excretion
data presented in the Figures IA and 3A, which are similar for all experimental rats.
Has a possible
interference of oxalate ions with the determination of
calcium been investigated methodologically?
Authors : In experimental rat nephrolithiasis, the urine
is supersaturated with calcium and oxalate. Precipitation
of the CaOx crystals decreases the urinary concentration
of free calcium and oxalate. This decrease is most obviously noticed in the calcium concentration, since, compared with oxalate, the urinary concentration of this ion
is low. We performed also a control experiment in
which we investigated the effect of vitamin D 3 . Compared with 0.5 % EG alone, we found that vitamin D 3 +
0.5 % EG does not enhance the calcium excretion (Table
4). Apparently, the administration of vitamin D 3 , which
has been reported to enhance the intestinal absorption of
calcium, did not compensate for this decrease in urinary
calcium.

J.P. Kavanagh: It is not clear to me how many rats
were used in the different experiments. It is also not
clear what the control data represent in the Figures 3, 5,
6, and 7.
Authors: In total, 33 rats were used . Twenty four rats
were used in the time course study, in which the calcium
and oxalate response of Wistar and SD rats was compared (Table 1). For the EG concentration studies, nine
rats were used, three for each group (group I-III).
Since, at day 0, all rats were fed the standard chow, in
this dietary study, the experimental rats of day O were
the control group (open bars in Figs. 3, 4, 5, 6 and 7).

H.G. Tiselius: To further emphasize the importance of
the present findings, I would like to read exactly what
conclusions the authors have drawn from these experiments with respect to the usefulness of this animal model. The impression I get is that, in addition to the unphysiologic concentrations of oxalate necessary for crystallization, there appears to be toxic effect on the kidney
that are so pronounced that the model seems useless in
studying stone formation. Do you agree?

J.P. Kavanagh: To say that in Figure 1, during the
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Table 4. The effect of vitamin D3 on the urinary excretion of calcium and oxalate in Wistar rats. In this study rats
were fed a CID of 1.5 % EG or a CID of vitamin D 3 + 1.5 % EG . At day O the rats were fed the standard diet. Data
are expressed as µ.mol/24 h (mean ± s.d.; n=3).

Experimental day

6

0

21

4

28

42

l.5%EG

Oxalate excretion

7.7

Calcium excretion

26.7

±
±

1.3
14.9

Vitamin D 3 + 1.5% EG
Oxalate excretion
8.7 ± 0.5

Calcium excretion

23.7

± 20.8

103.7
10.0

± 24.9
± 3.3

100.3 ± 42.7
9.3

± 2.9

34.7 ± 34.0 115.3 ± 26.7 114.7 ± 21.9
2.3 ± 0.5

0.0 ± 41.8
8.0

Authors: We agree that the rat, as model for nephrolithiasis, is based upon the creation of a rather unphysiologically high concentrations of oxalate in urine. However, in an accompanying paper [13), we show that high
oxalate concentration, on itself, does not lead to any
kidney damage. Specifically, it was found that the retained crystals give rise to morphological and cytochemical changes, including glomerular damage, enlargement
of the interstitium, tubular dilatation, increase of mitotic
activity of interstitial and tubular cells, and changes in
the staining pattern of Tamm-Horsfall protein . As such,
this rat model is suitable to study, in vivo, the interaction of the retained crystals with the surrounding interstitial and tubular cells. In the renal interstitium of rats,
four cell types have been described [48), and in preliminary experiments, we found that nearly all interstitial
crystals are surrounded by macrophages [13). Therefore, the present rat model is preeminently suitable to
study the interaction of interstitial cells, including
macrophages, lymphocytes, dendritic cells and fibroblasts, with interstitial and papillary crystals and to study
the contribution of these cells to kidney damage and
regeneration.

± 4.6

8.7

±

0.9

85.3 ± 21.0
13.0 ± 11.3

8.3

± 0.5

62.7 ± 6.9
7.7

±

1.3

98.0

± 36.1

6.7 ± 2.4

77.7 ± 11.9
11.3 ± 2.1

Additional References

[46) Ryall RG (1986). A computer model for the
determination of the extents of growth and aggregation
of crystals from changes in their size distribution. J
Crystal Growth 76, 290-299 .
[47] Cao LC, Deng G, Boeve ER, de Bruijn WC,
de Water R, Verkoelen CF, Romijn JC, Schroder FH
(1996). Zeta potential measurement and particle-size
analysis for a better understanding of urinary inhibitors
of calcium oxalate crystalliz.ation. Scanning Microsc 10,
401-414.
[48] Kaissling B, Le Hir M (1994). Characteriz.ation
and distribution of interstitial cell types in the renal
cortex of rats. Kidney Int 45, 709-720.

603

